Innovation Grant Awarded for Qu Biologics Project with University of Ottawa Scientist VANCOUVER, British Columbia, April 04, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...

Custodian Participation is Necessary to Adopt a Standardized Central Utility Model for SSI Data Management, finds TABB Group Study NEW YORK and LONDON, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Though the investment management industry has reached a point at which further progression to the utility model for standing settlement...

MacAulay-Brown Partners on IDIQ Contract Award for U.S. Special Operations Command DAYTON, Ohio, Jan. 11, 2016 (GLOBE NEWSWIRE) -- MacAulay-Brown, Inc. (MacB), a leading National Security company delivering advanced engineering services and product solutions to Defense,...